Back
HFA Premium Access

Exploring the clinical relevance of TSAT <21% as an iron deficiency indicator in pulmonary arterial hypertension: a comparative analysis with alternative criteria and existing guidelines

Session: ePosters in valvular and pulmonary 4
Topic: Pulmonary Hypertension
Speaker: Doctor N. Ilchyshyn (Almada, PT)
Event: Heart Failure 2024

Congress Presentation

Add to my library

Like

About the speaker

Doctor Nazar Ilchyshyn

Hospital Garcia de Orta, Almada (Portugal)
0 follower

3 more presentations in this session

Long-term survival outcomes and baseline hemodynamics in patients with PAH versus CTEPH

Speaker: Doctor J. Mesquita Guimaraes (Coimbra, PT)

Access
Abstract
Slides
Video
Like
Thumbnail

Real-world results of selexipag in treating pulmonary hypertension in a portuguese population

Speaker: Doctor J. Mesquita Guimaraes (Coimbra, PT)

Access
Abstract
Slides
Video
Like
Thumbnail

HFWM: exploring biomarkers in chronic thromboembolic pulmonary hypertension (CTEPH): prognostic significance, and post-PEA dynamics analysis

Speaker: Doctor A. Cuomo (Napoly, IT)

Access
Abstract
Slides
Video
Like
Thumbnail

Access the full session

ePosters in valvular and pulmonary 4

Speakers: Doctor N. Ilchyshyn, Doctor J. Mesquita Guimaraes, Doctor J. Mesquita Guimaraes, Doctor A. Cuomo
Access
Like
Thumbnail

About the event

Image

Heart Failure 2024

11 May - 14 May 2024

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources